Why lipase supplements fail on their own

Lipase is water-soluble and fat is not. Without emulsification first, the enzyme has almost nothing to grip.

---

A common pattern: greasy stools and heaviness after fatty food, so the person buys a high-strength digestive enzyme with a big lipase number on the label, takes it religiously, and gets very little back for it.

The reason is a constraint of physical chemistry rather than a dosing problem.

The interface problem

Triglycerides are hydrophobic. In the watery environment of the small intestine they coalesce into large droplets, minimising their contact with water.

Pancreatic lipase is water-soluble. It cannot dissolve into the interior of a fat droplet. It works only at the interface where water meets oil, which on a large droplet is a small fraction of the total fat present. Most of the fat is on the inside, unreachable.

Adding more enzyme does not change the geometry. You are increasing the number of workers without increasing the size of the work surface.

What bile salts contribute

Bile acids are facial amphiphiles: hydrophobic on one face of the steroid backbone, hydrophilic hydroxyl groups on the other. That structure lets them arrange around lipid droplets, lower interfacial tension, and break one large droplet into an enormous number of small ones.

The surface area available for the enzyme to work on increases by orders of magnitude. Emulsification is not a preparatory nicety. It is the step that makes the enzymatic one possible.

One detail worth adding, since it complicates the simple version: bile salts coating a droplet can actually block lipase from binding. The body solves this with colipase, a small protein secreted alongside lipase that anchors it to the bile-salt-covered interface. Fat digestion needs all three present, not two.

The practical implication

If bile delivery is the limiting factor, supplemental lipase is being added to a system that is already enzyme-sufficient and surface-area-poor. That is why the enzyme plateau is so common and so frustrating: the supplement is not defective, it is addressing the second bottleneck while the first one is untouched.

The corollary matters too. If your bile delivery is fine and the problem is genuinely pancreatic insufficiency, enzymes are exactly right and bile acids will not substitute for them. Working out which constraint you are actually under is the useful step, and it is a question for a clinician rather than a product label.

Educational and scientific information only. Tauroursodeoxycholic acid (TUDCA) is sold as a food supplement and has not been assessed by the Food Standards Agency, the MHRA, the European Food Safety Authority or the US Food and Drug Administration for preventing, treating or curing any disease. Ursodeoxycholic acid (UDCA) is a prescription-only medicine in the UK. Nothing here is a substitute for prescribed treatment. If you are under medical care or taking prescribed medication, speak to your doctor or pharmacist before starting any supplement.